Reply to Hiniker et al. (Phase I trial: SABR and ipilimumab – letter)

Por Tang, Chad, Welsh, James, Hong, David
Publicado no Clin Cancer Res (2017)

COGNITIVE PROFILE OF TURNER SYNDROME

Por Hong, David, Kent, Jamie Scaletta, Kesler, Shelli
Publicado em 2009

Psychosocial functioning and social cognitive processing in girls with Turner syndrome

Por Hong, David S., Dunkin, Bria, Reiss, Allan L.
Publicado em 2011

MET in ovarian cancer: Metastasis and resistance?

Por Tang, Chad, Jardim, Denis L, Hong, David
Publicado em 2014

Targeting translation initiation in breast cancer

Por Akcakanat, Argun, Hong, David S, Meric-Bernstam, Funda
Publicado no Translation (Austin) (2014)

Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report

Por Subbiah, Vivek, Hong, David S., Meric-Bernstam, Funda
Publicado no Proc Natl Acad Sci U S A (2016)

Reduced Functional Connectivity during Working Memory in Turner Syndrome

Por Bray, Signe, Dunkin, Bria, Hong, David S., Reiss, Allan L.
Publicado em 2011

Bevacizumab-Based Treatment in Colorectal Cancer with a NRAS Q61K Mutation

Por Janku, Filip, Wheler, Jennifer J., Hong, David S., Kurzrock, Razelle
Publicado em 2013

Aberrant functional network recruitment of posterior parietal cortex in turner syndrome

Por Bray, Signe, Hoeft, Fumiko, Hong, David S., Reiss, Allan L.
Publicado no Hum Brain Mapp (2012)

An appraisal of drug development timelines in the Era of precision oncology

Por Jardim, Denis Leonardo, Schwaederle, Maria, Hong, David S., Kurzrock, Razelle
Publicado no Oncotarget (2016)

Neuroanatomical Spatial Patterns in Turner Syndrome

Por Marzelli, Matthew J., Hoeft, Fumiko, Hong, David S., Reiss, Allan L.
Publicado em 2010

Genomic Imprinting Effects on Cognitive and Social Abilities in Prepubertal Girls with Turner Syndrome

Por Lepage, Jean-François, Hong, David S., Hallmayer, Joachim, Reiss, Allan L.
Publicado em 2012

Impact of cognitive profile on social functioning in prepubescent females with Turner syndrome

Por Lepage, Jean-François, Dunkin, Bria, Hong, David S., Reiss, Allan L.
Publicado em 2012

STAT3 Inhibitors: Finding a Home in Lymphoma and Leukemia

Por Munoz, Javier, Dhillon, Navjot, Janku, Filip, Watowich, Stephanie S., Hong, David S.
Publicado em 2014

Exosome-mediated drug resistance in cancer: the near future is here

Por Giallombardo, Marco, Taverna, Simona, Alessandro, Riccardo, Hong, David, Rolfo, Christian
Publicado no Ther Adv Med Oncol (2016)

Cross-Reactive Neutralizing Antibody against Pandemic 2009 H1N1 Influenza A Virus in Intravenous Immunoglobulin Preparations

Por HONG, DAVID K., TREMOULET, ADRIANA H., BURNS, JANE C., LEWIS, DAVID B.
Publicado em 2011

Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service

Por Parsons, Henrique A., Baracos, Vickie E., Dhillon, Navjot, Hong, David S., Kurzrock, Razelle
Publicado em 2012

Aberrant neurocognitive processing of fear in young girls with Turner syndrome

Por Hong, David S., Bray, Signe, Haas, Brian W., Hoeft, Fumiko, Reiss, Allan L.
Publicado em 2014

Cortical Brain Morphology in Young, Estrogen-Naive, and Adolescent, Estrogen-Treated Girls with Turner Syndrome

Por Lepage, Jean-Francois, Mazaika, Paul K., Hong, David S., Raman, Mira, Reiss, Allan L.
Publicado em 2013

The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer

Por Parsons, Henrique A., Baracos, Vickie E., Hong, David S., Abbruzzese, James, Bruera, Eduardo, Kurzrock, Razelle
Publicado no Oncotarget (2016)